Edwards Lifesciences SVP Andrew M. Dahl forfeited 253 shares at $84.37 per share. The transaction left him with 14,615 shares, giving investors the reported post-transaction ownership figure and showing that the forfeiture represented about 1.7% of his prior holdings.
Key Highlights
- Andrew M. Dahl held 14,615 Edwards Lifesciences shares after the transaction.
- The transaction occurred on 13 September 2026 under transaction code F.
- The forfeited amount represented about 1.7% of Dahl’s prior holdings.
Edwards Lifesciences Corp (NYSE: EW) recorded a forfeiture of 253 shares by Andrew M. Dahl at $84.37 per share. Dahl is the company’s SVP and Corporate Controller.
Dahl’s Post-Transaction Ownership
Dahl held 14,615 Edwards Lifesciences shares after the transaction. The forfeited shares represented about 1.7% of his prior holdings. The transaction involved Edwards Lifesciences shares forfeited at the stated per-share value. The reported post-transaction ownership figure refers to Dahl’s holdings after the forfeiture.
FAQs
Q: How many Edwards Lifesciences shares did Andrew Dahl forfeit?
A: Andrew M. Dahl forfeited 253 Edwards Lifesciences shares at $84.37 per share. He served as the company’s SVP and Corporate Controller.
Q: How many Edwards Lifesciences shares did Dahl retain?
A: Andrew M. Dahl held 14,615 Edwards Lifesciences shares after the transaction. The forfeiture represented about 1.7% of his prior holdings.
Q: What does transaction code F mean for Edwards Lifesciences?
A: For Edwards Lifesciences, transaction code F refers to a forfeiture of shares. Andrew M. Dahl forfeited 253 shares at $84.37 per share and held 14,615 shares after the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.